Steamboat Capital Partners, LLC Abb Vie Inc. Transaction History

Steamboat Capital Partners, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $2.94 Million - $3.96 Million	-36,486 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $38,659 - $45,373	-450 Reduced 1.22%	36,486 $3.2 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $2.71 Million - $3.63 Million	36,936 New	36,936 $3.63 Million

3,849

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $324B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Steamboat Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Steamboat Capital Partners, LLC with notifications on news.